Picture of ChromoGenics AB logo

CHRO — ChromoGenics AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro CapNeutral

Brief: Chromogenics Q3 Operating Loss Narrows To SEK 14.4 Mln

Nov 13 (Reuters) - ChromoGenics AB  CHRO.ST :
    * Q3 NET SALES FOR PERIOD AMOUNTED TO SEK 3.5 (14.0) MILLION
    * Q3 OPERATING LOSS AMOUNTED TO SEK -14.4 (-19.4) MILLION
    * NET SALES FOR CURRENT YEAR ARE THEREFORE EXPECTED TO BE
LOWER
THAN OUTCOME IN 2019
    * COST SAVINGS HAVE HAD GREATEST IMPACT IN Q3
    * CASH AND CASH EQUIVALENTS AMOUNTED TO SEK 21.3 (48.2)
MILLION ON
SEPTEMBER 30, 2020
    * CHROMOGENICS' ORDER BACKLOG AMOUNTED TO SEK 5.4 MILLION AT
END
OF Q3

Source text for Eikon:  ID:nWkr6c3qKt 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))

Recent news on ChromoGenics AB

See all news